ClinicalTrials.Veeva

Menu

Anticipatory & Preventive Team Care (APTCare): At Risk Patients of Family Health Networks

C

C. T. Lamont Primary Care Research Centre

Status and phase

Unknown
Phase 3
Phase 2

Conditions

Hypertension
Diabetes
Chronic Obstructive Pulmonary Disease
Congestive Heart Failure

Treatments

Behavioral: Self-management of chronic illness

Study type

Interventional

Funder types

Other

Identifiers

NCT00238836
APTCare

Details and patient eligibility

About

The University of Ottawa and Élisabeth Bruyère Research Institute are conducting a study of preventive care for frail patients at risk of functional decline. At risk patients are assigned by chance to continue receiving their standard care from their family physician or receive additional care from a nurse practitioners and a pharmacist. In collaboration with the family physician, they develop an individualized care plan, a treatment and management road plan, for each patient, which they implement over the study period of one approximately year. The objective of the study is to compare the effectiveness of the model of care that includes the nurse practitioners and pharmacist against standard care in preventing functional decline, to determine the acceptability of this model of care to patients, their caregivers and the medical team, and to evaluate the cost implication of the program.

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 50 years and over
  • 'At Risk' by having one or more of the following: a. Visits to emergency dept within the past 6 months; b. Admission to hospital for a medical problem in past 6 months; c. High service use profiles; d. Polypharmacy; e. Other high risk factors
  • Capable of giving informed consent
  • Able to use the Care Companion technology

Exclusion criteria

  • Cognitive impairment such that they cannot give informed consent
  • Unable or unwilling to use the telehomecare equipment
  • Unlikely to tolerate the intensive intervention
  • Language or cultural barriers
  • Being acutely ill or having an unstable condition on entry to the study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems